LGND

Ligand Pharmaceuticals Incorporated News Headlines

$50.85
*  
0.42
0.83%
Get LGND Alerts
*Delayed - data as of Sep. 16, 2014  -  Find a broker to begin trading LGND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LGND After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

NASDAQ Biotechnology Top Performers (As Of Market Open September 11)
9/11/2014 8:27:38 AM - David Krein

Ligand Inks 2nd Captisol Deal with CURx Pharmaceuticals - Analyst Blog
9/10/2014 5:00:00 PM - Zacks.com

Update: Ligand Establishes License Agreement With CURx Pharmaceuticals
9/9/2014 1:31:00 PM - Seeking Alpha

Diabetes biotech Viking Therapeutics sets terms for $55 million IPO
9/2/2014 5:20:01 PM - Renaissance Capital

Ligand's Partner GSK Gets FDA Approval Of SNDA For Promacta/Revolade
8/27/2014 8:15:00 AM - RTT News

Ligand Pharmaceuticals: Institutional Holders Wasting No Time Dumping Stock In Response To Mounting Insolvency And Bankruptcy Risks
8/22/2014 3:15:00 PM - Seeking Alpha

Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog
8/18/2014 5:10:00 PM - Zacks.com

LGND Does A Deal, Q2 Revenue A Bitter Pill For BGMedicine, CRMD On Watch
8/14/2014 11:02:00 PM - RTT News

Update: Ligand's New License Agreement Strengthens Portfolio
8/14/2014 12:58:00 PM - Seeking Alpha

Ligand Pharma Inks Deal With Avion To Develop Captisol-enabled Programs
8/14/2014 8:17:00 AM - RTT News

Ligand Gains on Q2 Earnings Beat, Increases Guidance - Analyst Blog
8/7/2014 11:32:00 AM - Zacks.com

Ligand Pharmaceuticals (LGND) Jumps: Stock Up 10.1% - Tale of the Tape
8/5/2014 9:25:00 AM - Zacks.com

Update: Lemelson Capital Further Increases Short Stake In Ligand Pharmaceuticals As EPS Plunges 76% In Q2 2014
8/4/2014 3:10:00 PM - Seeking Alpha

Update: Ligand Earnings - Strong Q2-Growth Beats Expectations
8/4/2014 1:45:00 PM - Seeking Alpha

Ligand: Pipeline Breakdown Reveals Bullish Outlook
7/30/2014 9:12:00 AM - Seeking Alpha

Ligand Pharmaceuticals - The Bull Case
7/7/2014 12:02:00 PM - Seeking Alpha

Ligand Pharmaceuticals: Appendix
7/3/2014 12:04:00 PM - Seeking Alpha

Glaxo's Promacta in Phase III for MDS - Analyst Blog
6/26/2014 2:30:00 PM - Zacks.com

Ligand Pharma-TG Therapeutics Collaborate on IRAK4 Inhibitors - Analyst Blog
6/25/2014 4:30:00 PM - Zacks.com

TG Therapeutics Inc. (TGTX) Has Surged To A New High After License Agreement
6/24/2014 9:51:00 AM - RTT News

Capital Allocation As Stewardship (Video)
6/19/2014 3:53:00 PM - Seeking Alpha

Glaxo's Promacta Holds Promise - Analyst Blog
6/17/2014 4:45:00 PM - Zacks.com

Ligand Pharma's LGD-6972 Positive in Phase I Study - Analyst Blog
6/17/2014 4:35:00 PM - Zacks.com

Interesting LGND Put And Call Options For November 22nd
6/17/2014 11:05:55 AM - BNK Invest

Bearish outlook for Ligand from Lemelson Capital
6/16/2014 4:44:00 PM - Seeking Alpha